LOS ANGELES, June 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) said Sunday that kid-sized doses of Pfizer-BioNTech's COVID-19 vaccine appear to be safe and effective for children aged under 5. The analysis by FDA scientists was posted online ahead of a meeting scheduled...
If a new vaccine makes it through all these trials, and the FDA finds that the results meet their requirements for safety and effectiveness, the vaccine will be approved. In some cases, as with theCOVID 19 vaccines, there may be an emergency use approval before full approval. COVID 19 V...
The US Food and Drug Administration (FDA) "will not delay, but will not cut corners" in approving a covid-19 vaccine, its commissioner Stephen Hahn promised a Senate hearing on 23 September, setting up a potential confrontation with President Trump. Any decision will be made by the agency'...
The agency will continue to monitor the safety of the Janssen COVID-19 Vaccine and all other vaccines, and as has been the case throughout the pandemic, will thoroughly evaluate new safety information," Marks said. To date, nearly 17 million Americans have received the Johnson & Johnson ...
An analysis that included 1,005 vaccine participants in this age group found the vaccine was 100% effective in preventing COVID-19.
The Johnson & Johnson COVID-19 vaccine was authorized for emergency use in the United States on Feb. 27, 2021. Through March 18 this year, the FDA and the U.S. Centers for Disease Control and Prevention have identified 60 confirmed TTS cases, including nine fatal cases, according to the...
Asked about skepticism of Covid vaccines on Monday, PresidentDonald Trump’scoronavirus vaccine czar, Dr. Moncef Slaoui, told CNBC that he is “very concerned” about it. “Over the last several months, the politicization, the context under which the vaccine development has taken place has exac...
“The U.S. now has access to the Novavax COVID-19 Vaccine, adjuvanted, the first protein-based option, as a booster,” Novavax President and CEO Stanley Erck said in a news release. “According to CDC data, almost 50 percent of adults who received their primary series have yet to re...
A group of advisors has been asked by the FDA to set aside three days early next month for possible meetings, a critical component to the agency’s authorization process for a Covid-19 vaccine,CNBC reported earlier Wednesday. People familiar with the plans told CNBC’s Meg Tirrell the adv...
"We now have another fully approved COVID-19 vaccine," said CDC Director Rochelle Walensky in a statement. "If you have been waiting for approval before getting vaccinated, now is the time to join the nearly 212 million Americans who have already completed their primary series. CDC continues ...